Ki67-BCL2 index in prognosis of malignant peritoneal mesothelioma. - Wikidata - wikimedia - TriplyDB

Ki67-BCL2 index in prognosis of malignant peritoneal mesothelioma.

Ki67-BCL2 index in prognosis of malignant peritoneal mesothelioma.

http://www.wikidata.org/entity/Q37096479

about

Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study.Targeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tumour growth in mouse xenograft models.

P2860

Q35678741-58D63FE9-F54D-4AE1-907D-A745677BAD03 Q47107902-B38359AC-7528-4875-94F3-65E0355AEC22

P2860

Ki67-BCL2 index in prognosis of malignant peritoneal mesothelioma.

http://www.wikidata.org/entity/Q37096479

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 14 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Ki67-BCL2 index in prognosis of malignant peritoneal mesothelioma.

@en

Ki67-BCL2 index in prognosis of malignant peritoneal mesothelioma.

@nl

type

label

Ki67-BCL2 index in prognosis of malignant peritoneal mesothelioma.

@en

Ki67-BCL2 index in prognosis of malignant peritoneal mesothelioma.

@nl

prefLabel

Ki67-BCL2 index in prognosis of malignant peritoneal mesothelioma.

@en

Ki67-BCL2 index in prognosis of malignant peritoneal mesothelioma.

@nl

P1433

Q37096479-D9047E6D-CA97-4A6B-9735-7C24D03D24DE

P1476

Q37096479-E96BFB5B-DC6C-4C13-B2BA-0F8C4069F3F1

P2093

Q37096479-1FB60657-FE40-4E92-A188-42C1F36D628D

Q37096479-6A25CED3-6187-460A-971A-2EC7FF737BF5

Q37096479-89764D2A-5969-415B-B15A-D2208173967B

Q37096479-BA59A646-FEB3-48B7-8D59-2505547CF276

P2860

Q37096479-01F52146-F476-460A-B9EC-677CF65DED40

Q37096479-0289327A-67C6-4E72-882F-0AB382AC3FD9

Q37096479-02B14710-8BA3-41FD-893C-BD66994988BC

Q37096479-0A9DE75B-E61A-4EC7-986E-909BF08FCFCC

Q37096479-0AED083D-A4A8-4AB4-89BF-106C3E7E5972

Q37096479-156CB64C-3A93-4DD3-A7BB-EF8BEA645D5A

Q37096479-1B3CF064-CE99-4276-B5D4-CC206BC104CE

Q37096479-1F119947-5FED-4BC7-8ACE-99A8FDFBAAB8

Q37096479-20CD5F3D-24E4-4F32-9FB5-B92F6C040998

Q37096479-22F1849A-BE3F-4CAF-9155-334C63145156

P304

Q37096479-C0A8B355-780F-49CB-98A5-BAEE3A3B7528

P31

Q37096479-5E2B4789-2557-46BD-9EE6-C0366F23653F

P433

Q37096479-AA4A41F6-C91A-4E11-ADF3-A2EE9BC64AFD

P478

Q37096479-592091E9-D41C-403C-9521-8E7D6DADF0E9

P577

Q37096479-DC6F02A7-94C9-48F0-9D75-68B83B0DD4AF

P698

Q37096479-637A6C3E-CF01-48E2-A517-2E1FC75D6D4C

P932

Q37096479-14BEB422-BD60-4763-8817-4544576E3B47

P1433

American Journal of Cancer Research

P1476

Ki67-BCL2 index in prognosis of malignant peritoneal mesothelioma.

@en

P2093

David L Morris

http://www.w3.org/2001/XMLSchema#string

Krishna Pillai

http://www.w3.org/2001/XMLSchema#string

Mohammad H Pourgholami

http://www.w3.org/2001/XMLSchema#string

Terence C Chua

http://www.w3.org/2001/XMLSchema#string

P2860

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

Peritoneal mesothelioma: a review

Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

Lung cancer mortality is related to age in addition to duration and intensity of cigarette smoking: an analysis of CPS-I data.

Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer

Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer.

Ki-67 expression in gastric cancer. Results from a prospective study with long-term follow-up.

Estrogen receptor β exerts tumor repressive functions in human malignant pleural mesothelioma via EGFR inactivation and affects response to gefitinib

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.

P304

411-423

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23977450

http://www.w3.org/2001/XMLSchema#string

P932

3744020

http://www.w3.org/2001/XMLSchema#string